Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Biopsy × Head & Neck × Clear all

Phase

Phase 2 19 Phase NA 14 Phase 1 8 Phase 1/2 4 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 9 Other hematologic neoplasm 8 Gastrointestinal 5 Sarcoma 3 Genitourinary 3 Breast 3 Plasma cell 2 Myeloid 2 CNS 2 Thoracic 1 Head & Neck 1 Gynecologic 1 Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 124 Radiotherapy 58 Fluorouracil 43 Radiotherapy, Intensity-Modulated 41 Docetaxel 35 Gemcitabine 33 Cetuximab 31 Carboplatin 25 pembrolizumab 22 Capecitabine 20 Drug Therapy 16 Paclitaxel 14 toripalimab 13 Nivolumab 10 Surgical Procedures, Operative 9 nimotuzumab 8 camrelizumab 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Chemoradiotherapy 8 nedaplatin 7 Chemotherapy, Adjuvant 7 tislelizumab 6 Standard of Care 6 Specimen Handling 6 Radiation 6 Platinum 6 Neoadjuvant Therapy 6 Iodine-131 6 Induction Chemotherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03519048 2024-03-26

SURVEILL'ORL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡